IL1B and disease of the tendon: Although the key cytokines in tendon disease have not yet been fully defined, family members of the interleukin-1 (Il-1) family, in particular Il-1β, can trigger catabolic degradation of the ECM via the activation of MMPs, thereby contributing to the progression of tendinopathy [8,9].